HM
VCYT icon

HealthCor Management’s Veracyte VCYT Stock Holding History

HealthCor Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-119,710
Closed -$4.93M – 72
2021
Q4 		$4.93M Buy
119,710
+70,070
+141% +$3.1M 0.27% 50
2021
Q3 		$2.31M Buy
+49,640
New +$2.17M 0.1% 58

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

HealthCor Management's VCYT Position: Q1 2022 in Review

HealthCor Management sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 119,710 shares — an estimated $4.93M sold.

HealthCor Management first reported a position in VCYT in Q3 2021 and held it in 2 quarters. The position peaked at $4.93M in Q4 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • HealthCor Management reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • HealthCor Management sold 119,710 Veracyte shares in Q1 2022, an estimated $4.93M.
  • HealthCor Management first reported a position in Veracyte in Q3 2021 and held it in 2 quarters.
  • HealthCor Management's Veracyte position peaked at $4.93M in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on HealthCor Management's 13F filing for Q1 2022, filed 16 May 2022.